Corpus ID: 13909406

Imaging characteristics after pancreatic IRE

  title={Imaging characteristics after pancreatic IRE},
  author={Hester J. Scheffer and Laurien G. P. H. Vroomen and M. Cam and Melenhorst and Marcus C. de Jong and Geert Kazemier},
MR and CT imaging characteristics and ablation zone geometry of locally advanced pancreatic carcinoma treated with irreversible electroporation Abstract Purpose To assess specific imaging characteristics after percutaneous irreversible electroporation (IRE) for locally advanced pancreatic carcinoma (LAPC) with multiphasic contrast-enhanced (ce) MRI and ceCT and to explore the correlation of these characteristics to the development of recurrence. Methods Qualitative and quantitative analyses of… Expand

Figures and Tables from this paper


CT Findings of Patients Treated with Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Introduction. In patients with locally advanced pancreatic cancer (LAPC), IRE has been shown to be safe for local disease control and palliation. As IRE continues to gain acceptance it is importantExpand
Assessment of tumor response on MR imaging after locoregional therapy.
The role of MR imaging in assessing treatment response after various locoregional therapies is described and the role of tumor size and lesion enhancement as well as ADC mapping is described. Expand
Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.
In an animal model, IRE proved to be a fast, safe, and potent ablative method, causing complete tissue death by means of apoptosis, suggesting involvement of the apoptotic process in the pathophysiology of cell death caused by IRE. Expand
Spectrum of imaging and characteristics for liver tumors treated with irreversible electroporation
Imaging findings from IRE liver tumor treatments from ultrasound, computed tomography, magnetic resonance, and positron emission tomography are presented and tumor treatments in regions adjacent to sensitive structures that contraindicate thermal therapies are presented. Expand
Pancreatic adenocarcinoma: MRI conspicuity and pathologic correlations
3D FS T1 GRE arterial phase imaging produces greater pancreatic adenocarcinoma conspicuity compared to DWI but underestimates tumor size, while DWI provides the best size evaluation but fails to delineate the tumor in one-fourth of cases. Expand
US findings after irreversible electroporation ablation: radiologic-pathologic correlation.
The ablation zone can be best predicted by measuring the external hyperechoic rim that forms 90-120 minutes after ablation, which is possibly attributable to evolving hemorrhagic infiltration via widened sinusoids. Expand
Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
Findings on contrast-enhanced computed tomography images of malignant hepatic tumors 24-72 hours after percutaneous ablation by irreversible electroporation (IRE) and at midterm follow-up are described to distinguish normal results after intervention from complications requiring further treatment. Expand
Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study
This ablate-and-resect study demonstrated avitality caused by IRE of CRLM in humans, and local electrical heterogeneities of tumour tissue may require tumour-specific ablation protocols. Expand
Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.
IR-prepared contrast-enhanced MR imaging can be used to quantitatively measure IRE ablation zones in the liver in a rat model and permits accurate depiction of ablated tissue zones after IRE procedures, according to Bland-Altman plots. Expand
Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study
Irreversible Electroporation is a safe procedure in patients with LAPC and may represent a new technological option in the treatment and multimodality management of this disease. Expand